PRLD Prelude Therapeutics Incorporated - Common Stock
$5,80
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 11, 2026
52W-Spanne
$1–$6
98% of range
Analystenbewertung
BUY
9 analysts
Kursziel
$8
+38% upside
P/E (TTM)
-2.2
ROE
-137.7%
Nettogewinnmarge
-819.6%
PRLD Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$5.80
Marktkapitalisierung
—
P/E (TTM)
-2.2
EPS (TTM)
$-1.29
Umsatz (TTM)
$12M
Dividendenrendite
—
ROE
-137.7%
Verschuldungsgrad
—
52W-Spanne
$1 – $6
PRLD Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$12M
2024-12-31
→
2025-12-31
EPS
$-1.29
2021-12-31
→
2025-12-31
Freier Cashflow
$-56M
2020-12-31
→
2025-12-31
Margen
-819.6%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
PRLD
Peer-Median
P/E (TTM)
-2.2
19.6
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
PRLD
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-861.3%
—
Net Profit Margin (Nettogewinnmarge)
-819.6%
-298.0%
ROA
-62.8%
-56.6%
ROE
-137.7%
-70.8%
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
PRLD
Peer-Median
Current Ratio (Liquiditätsgrad)
2.0
5.2
Quick Ratio
1.9
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
PRLD
Peer-Median
Revenue YoY (Umsatz YoY)
73.4%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
PRLD
Peer-Median
PRLD Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
9 Analysten
- Starker Kauf 3 33,3%
- Kauf 5 55,6%
- Halten 1 11,1%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
3 Analysten · 2026-08-13
Median
$8.00
← Unter allen Zielen
$5.80
Tief
$6.00
Hoch
$10.00
Median-Ziel
$8.00
+37,9%
Mittelwert-Ziel
$8.00
+37,9%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.03%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 31. März 2026 | $-0.13 | $-0.25 | 0.12% |
| 31. Dezember 2025 | $-0.20 | $-0.03 | -0.17% |
| 30. September 2025 | $-0.26 | $-0.37 | 0.11% |
| 30. Juni 2025 | $-0.41 | $-0.45 | 0.04% |
| 31. März 2025 | $-0.42 | $-0.48 | 0.06% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| PRLD | — | -2.2 | 73.4% | -819.6% | -137.7% | — |
| ARTV | — | -1.3 | -99.2% | — | — | — |
| OVID | $212M | -4.0 | 1181.3% | -240.1% | -18.7% | — |
| KYTX | $568M | -2.6 | — | — | -77.4% | — |
| CCCC | $185M | -1.5 | 1.0% | -292.1% | -48.8% | — |
| EVMN | $540M | -1.5 | 85.7% | -529.8% | -401.2% | — |
| VSTM | $600M | -2.6 | 209.1% | -677.6% | -449.2% | — |
| ZURA | — | — | — | — | — | — |
| CABA | $220M | -1.0 | — | — | -115.5% | — |
| MPLT | $773M | -0.9 | — | — | -151.1% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 13
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue | $12M | $7M | |
| R&D Expense | $94M | $118M | |
| SG&A Expense | $22M | $29M | |
| Operating Expenses | $117M | $147M | |
| Operating Income | $-105M | $-140M | |
| Other Non-op | $5M | $13M | |
| Income Tax | $0 | $0 | |
| Net Income | $-99M | $-127M | |
| EPS (Basic) | $-1.29 | $-1.68 | |
| EPS (Diluted) | $-1.29 | $-1.68 | |
| Shares (Basic) | 76,956,194 | 75,805,840 | |
| Shares (Diluted) | 76,956,194 | 75,805,840 | |
| EBITDA | $-103M | $-138M |
Bilanz 18
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $35M | $12M | |
| Short-term Investments | $68M | $121M | |
| Prepaid Expense | $2M | $2M | |
| Current Assets | $106M | $136M | |
| PP&E (Net) | $5M | $7M | |
| PP&E (Gross) | $12M | $12M | |
| Accum. Depreciation | $7M | $5M | |
| Total Assets | $141M | $176M | |
| Accounts Payable | $4M | $8M | |
| Accrued Liabilities | $13M | $15M | |
| Current Liabilities | $53M | $26M | |
| Capital Leases | $15M | $15M | |
| Other Non-current Liabilities | $3M | $3M | |
| Total Liabilities | $73M | $44M | |
| Retained Earnings | $-683M | $-584M | |
| AOCI | $8.0K | $35.0K | |
| Stockholders' Equity | $69M | $131M | |
| Liabilities + Equity | $141M | $176M |
Cashflow 11
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| D&A | $2M | $2M | |
| Stock-based Comp | $12M | $21M | |
| Restructuring | $1M | · | |
| Other Non-cash | $30M | $1M | |
| Operating Cash Flow | $-56M | $-103M | |
| CapEx | $67.0K | $764.0K | |
| Investing Cash Flow | $53M | $90M | |
| Financing Cash Flow | $25M | $-120.0K | |
| Net Change in Cash | $22M | $-13M | |
| Taxes Paid | $0 | $0 | |
| Free Cash Flow | $-56M | $-104M |
Rentabilität 5
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -861.3% | -1995.9% | |
| Net Margin | -819.6% | -1816.8% | |
| EBITDA Margin | -847.2% | -1970.6% | |
| ROA | -62.8% | -56.1% | |
| ROE | -137.7% | -88.3% |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 2.0 | 5.3 | |
| Quick Ratio | 1.9 | 5.2 |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.1 | 0.0 |
Wachstumsraten 1
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | 73.4% | · |
Bewertung (TTM) 4
| Kennzahl | Trend | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $12M | $7M | |
| Net Income TTM | $-99M | $-127M | |
| P/E | -2.2 | -0.8 | |
| Earnings Yield | -44.5% | -131.8% |
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6M | $5M | $6M | $6M | $0 | $0 | $4M | $3M | |
| R&D Expense | $16M | $14M | $18M | $22M | $26M | $29M | $32M | $29M | |
| SG&A Expense | $5M | $5M | $5M | $5M | $6M | $6M | $6M | $8M | |
| Operating Expenses | $21M | $19M | $23M | $27M | $32M | $35M | $38M | $37M | |
| Operating Income | $-15M | $-14M | $-17M | $-20M | $-32M | $-35M | $-34M | $-34M | |
| Other Non-op | $2M | $4M | $891.0K | $693.0K | $963.0K | $3M | $5M | $2M | |
| Net Income | $-14M | $-10M | $-16M | $-20M | $-31M | $-32M | $-29M | $-32M | |
| EPS (Basic) | $-0.14 | $-0.13 | $-0.20 | $-0.26 | $-0.41 | $-0.42 | $-0.37 | $-0.43 | |
| EPS (Diluted) | $-0.14 | $-0.13 | $-0.20 | $-0.26 | $-0.41 | $-0.42 | $-0.37 | $-0.43 | |
| Shares (Basic) | 98,388,593 | 82,519,981 | -151,156,365 | 76,132,337 | 75,993,941 | 75,986,281 | -151,548,215 | 75,855,949 | |
| Shares (Diluted) | 98,388,593 | 82,519,981 | -151,156,365 | 76,132,337 | 75,993,941 | 75,986,281 | -151,548,215 | 75,855,949 | |
| EBITDA | $-15M | $-14M | · | $-20M | $-32M | $-34M | · | $-34M |
Bilanz 18
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $26M | $22M | $35M | $48M | $26M | $40M | $12M | $11M | |
| Short-term Investments | $125M | $60M | $68M | $7M | $47M | $59M | $121M | $142M | |
| Prepaid Expense | $3M | $3M | $2M | $3M | $4M | $3M | $2M | $3M | |
| Current Assets | $155M | $85M | $106M | $58M | $77M | $102M | $136M | $156M | |
| PP&E (Net) | $4M | $5M | $5M | $6M | $6M | $6M | $7M | $7M | |
| PP&E (Gross) | · | · | $12M | · | · | · | $12M | · | |
| Accum. Depreciation | · | · | $7M | · | · | · | $5M | · | |
| Total Assets | $189M | $120M | $141M | $95M | $115M | $141M | $176M | $197M | |
| Accounts Payable | $2M | $2M | $4M | $3M | $5M | $6M | $8M | $6M | |
| Accrued Liabilities | $8M | $6M | $13M | $13M | $13M | $11M | $15M | $14M | |
| Current Liabilities | $38M | $42M | $53M | $18M | $21M | $20M | $26M | $22M | |
| Capital Leases | $15M | $15M | $15M | $15M | $15M | $15M | $15M | $15M | |
| Other Non-current Liabilities | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Total Liabilities | $56M | $59M | $73M | $36M | $39M | $38M | $44M | $41M | |
| Retained Earnings | $-707M | $-693M | $-683M | $-667M | $-647M | $-616M | $-584M | $-555M | |
| AOCI | $-227.0K | $-41.0K | $8.0K | $2.0K | $-1.0K | $12.0K | $35.0K | $167.0K | |
| Stockholders' Equity | $134M | $60M | $69M | $59M | $76M | $103M | $131M | $156M | |
| Liabilities + Equity | $189M | $120M | $141M | $95M | $115M | $141M | $176M | $197M |
Cashflow 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $353.0K | $391.0K | $418.0K | $425.0K | $433.0K | $435.0K | $489.0K | $405.0K | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $4M | $4M | $4M | $6M | |
| Restructuring | $0 | $0 | $851.0K | $0 | · | · | · | · | |
| Other Non-cash | · | $-14M | · | · | · | $-6M | · | · | |
| Operating Cash Flow | $-16M | $-22M | $23M | $-19M | $-26M | $-34M | $-21M | $-27M | |
| CapEx | $0 | $0 | $0 | $0 | $20.0K | $47.0K | $53.0K | $63.0K | |
| Investing Cash Flow | $-66M | $8M | $-60M | $40M | $12M | $62M | $22M | $11M | |
| Financing Cash Flow | $86M | $-314.0K | $25M | $-5.0K | $37.0K | $-160.0K | $-34.0K | $-131.0K | |
| Net Change in Cash | $5M | $-14M | $-12M | $21M | $-15M | $28M | $1M | $-17M | |
| Free Cash Flow | · | $-22M | · | · | · | $-34M | · | · |
Rentabilität 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -270.9% | -309.5% | · | -314.1% | · | · | · | -1145.9% | |
| Net Margin | -244.1% | -226.8% | · | -303.5% | · | · | · | -1075.7% | |
| EBITDA Margin | -270.9% | -301.0% | · | -314.1% | · | · | · | -1145.9% | |
| ROA | -9.2% | -8.0% | · | -13.5% | -18.4% | -16.5% | · | -14.2% | |
| ROE | -13.3% | -12.7% | · | -18.4% | -24.2% | -20.4% | · | -16.4% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.1 | 2.0 | · | 3.2 | 3.7 | 5.2 | · | 7.0 | |
| Quick Ratio | 4.0 | 2.0 | · | 3.0 | 3.5 | 5.0 | · | 6.9 |
Effizienz 1
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | · | · | · | 0.0 |
Bewertung (TTM) 4
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $17M | · | · | · | · | · | · | · | |
| Net Income TTM | $-75M | $-93M | · | $-115M | $-130M | $-131M | · | $-129M | |
| P/E | -5.7 | -2.8 | · | -0.9 | -0.5 | -0.4 | · | -1.2 | |
| Earnings Yield | -17.6% | -35.7% | · | -105.6% | -212.6% | -225.3% | · | -85.0% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $12M | $7M | — | — | — |
| Betriebsgewinnmarge % | -861.3% | -1995.9% | — | — | — |
| Nettoergebnis | $-99M | $-127M | $-122M | $-115M | $-112M |
| Verwässerte EPS | $-1.29 | $-1.68 | $-2.02 | $-2.44 | $-2.43 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 2.0 | 5.3 | 10.8 | 9.4 | 15.4 |
| Quick Ratio | 1.9 | 5.2 | 10.7 | 9.3 | 15.2 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-56M | $-104M | $-111M | $-87M | $-86M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 86 Einreicher · $247.5M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 43 (+32 vs. Vorquartal) | 11 (+7 vs. Vorquartal) | 21 (+2 vs. Vorquartal) | 9 (-1 vs. Vorquartal) | +18.1M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | $73.151.963 | 13.724.571 | 29,56% | Aktien |
| BAKER BROS. ADVISORS LP | $53.959.982 | 10.123.824 | 21,80% | Aktien |
| RA CAPITAL MANAGEMENT, L.P. | $34.516.451 | 6.475.882 | 13,95% | Aktien |
| Soleus Capital Management, L.P. | $18.006.755 | 3.378.378 | 7,28% | Aktien |
| Kynam Capital Management, LP | $12.872.414 | 2.415.087 | 5,20% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $10.710.342 | 2.009.445 | 4,33% | Aktien |
| SPHERA FUNDS MANAGEMENT LTD. | $5.435.705 | 1.019.832 | 2,20% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $5.294.657 | 993.369 | 2,14% | Aktien |
| ADAR1 Capital Management, LLC | $4.801.797 | 900.900 | 1,94% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $4.503.813 | 844.993 | 1,82% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $4.083.286 | 766.095 | 1,65% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $3.751.819 | 703.768 | 1,52% | Aktien |
| STATE STREET CORP | $2.285.435 | 428.787 | 0,92% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.518.442 | 284.886 | 0,61% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $1.498.796 | 281.200 | 0,61% | Aktien |
| MORGAN STANLEY | $1.482.881 | 278.214 | 0,60% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.033.594 | 193.920 | 0,42% | Aktien |
| TWO SIGMA ADVISERS, LP | $688.170 | 237.300 | 0,28% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $664.571 | 124.685 | 0,27% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $591.630 | 111.000 | 0,24% | Kaufoption |
| VANGUARD GROUP INC | $456.402 | 157.380 | 0,18% | Aktien |
| Hillsdale Investment Management Inc. | $433.862 | 81.400 | 0,18% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $360.425 | 67.622 | 0,15% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $343.785 | 64.500 | 0,14% | Aktien |
| JANE STREET GROUP, LLC | $341.653 | 64.100 | 0,14% | Kaufoption |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $339.521 | 63.700 | 0,14% | Verkaufsoption |
| Squarepoint Ops LLC | $317.348 | 59.540 | 0,13% | Aktien |
| BlackRock, Inc. | $271.505 | 50.939 | 0,11% | Aktien |
| GOLDMAN SACHS GROUP INC | $265.199 | 49.756 | 0,11% | Aktien |
| PANAGORA ASSET MANAGEMENT INC | $253.569 | 47.574 | 0,10% | Aktien |
| Mariner, LLC | $241.241 | 45.261 | 0,10% | Aktien |
| Nuveen, LLC | $197.333 | 37.023 | 0,08% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $176.594 | 33.132 | 0,07% | Aktien |
| Cerity Partners LLC | $175.224 | 32.875 | 0,07% | Aktien |
| State of Wyoming | $175.154 | 32.862 | 0,07% | Aktien |
| CITADEL ADVISORS LLC | $166.829 | 31.300 | 0,07% | Verkaufsoption |
| Graham Capital Management, L.P. | $158.674 | 29.770 | 0,06% | Aktien |
| WELLS FARGO & COMPANY/MN | $134.982 | 25.325 | 0,05% | Aktien |
| BANK OF AMERICA CORP /DE/ | $127.254 | 23.875 | 0,05% | Aktien |
| RHUMBLINE ADVISERS | $117.649 | 22.074 | 0,05% | Aktien |
| JANE STREET GROUP, LLC | $107.133 | 20.100 | 0,04% | Verkaufsoption |
| Bank of New York Mellon Corp | $102.618 | 19.253 | 0,04% | Aktien |
| Vanguard Global Advisers, LLC | $86.399 | 16.210 | 0,03% | Aktien |
| CITADEL ADVISORS LLC | $85.813 | 16.100 | 0,03% | Kaufoption |
| MARSHALL WACE, LLP | $83.845 | 15.731 | 0,03% | Aktien |
| ExodusPoint Capital Management, LP | $82.482 | 15.475 | 0,03% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $75.686 | 14.200 | 0,03% | Aktien |
| HSBC HOLDINGS PLC | $74.403 | 13.652 | 0,03% | Aktien |
| MANGROVE PARTNERS IM, LLC | $71.166 | 13.352 | 0,03% | Aktien |
| Qube Research & Technologies Ltd | $69.876 | 13.110 | 0,03% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $68.139 | 12.784 | 0,03% | Aktien |
| BARCLAYS PLC | $66.811 | 12.535 | 0,03% | Aktien |
| CITIGROUP INC | $60.927 | 11.431 | 0,02% | Aktien |
| Invesco Ltd. | $59.008 | 11.071 | 0,02% | Aktien |
| Spark Investment Management LLC | $56.498 | 10.600 | 0,02% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $55.922 | 10.492 | 0,02% | Aktien |
| CITADEL ADVISORS LLC | $54.531 | 10.231 | 0,02% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $36.013 | 10.530 | 0,01% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $34.272 | 6.430 | 0,01% | Aktien |
| FMR LLC | $30.003 | 5.629 | 0,01% | Aktien |
| STRS OHIO | $29.315 | 5.500 | 0,01% | Aktien |
| NORTHERN TRUST CORP | $23.154 | 4.344 | 0,01% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $21.874 | 4.104 | 0,01% | Aktien |
| Nuveen Asset Management, LLC | $21.416 | 16.797 | 0,01% | Aktien |
| GROUP ONE TRADING LLC | $20.824 | 3.907 | 0,01% | Aktien |
| Legal & General Group Plc | $14.386 | 2.699 | 0,01% | Aktien |
| Ameritas Investment Partners, Inc. | $13.432 | 2.520 | 0,01% | Aktien |
| Tower Research Capital LLC (TRC) | $12.669 | 2.377 | 0,01% | Aktien |
| Russell Investments Group, Ltd. | $11.832 | 2.220 | 0,00% | Aktien |
| JPMORGAN CHASE & CO | $9.318 | 1.890 | 0,00% | Aktien |
| NISA INVESTMENT ADVISORS, LLC | $8.709 | 1.634 | 0,00% | Aktien |
| ROYAL BANK OF CANADA | $5.000 | 958 | 0,00% | Aktien |
| Quarry LP | $4.024 | 755 | 0,00% | Aktien |
| DEUTSCHE BANK AG\ | $3.950 | 741 | 0,00% | Aktien |
| ACADIAN ASSET MANAGEMENT LLC | $3.253 | 611.359 | 0,00% | Aktien |
| PNC Financial Services Group, Inc. | $2.308 | 433 | 0,00% | Aktien |
| CWM, LLC | $1.960 | 573 | 0,00% | Aktien |
| Fortitude Family Office, LLC | $1.226 | 230 | 0,00% | Aktien |
| Sterling Capital Management LLC | $517 | 97 | 0,00% | Aktien |
| UBS Group AG | $123 | 23 | 0,00% | Aktien |
| PRICE T ROWE ASSOCIATES INC /MD/ | $122 | 22.758 | 0,00% | Aktien |
| SBI Securities Co., Ltd. | $117 | 22 | 0,00% | Aktien |
| Caitong International Asset Management Co., Ltd | $96 | 18 | 0,00% | Aktien |
| GSA CAPITAL PARTNERS LLP | $68 | 12.672 | 0,00% | Aktien |
| MERCER GLOBAL ADVISORS INC /ADV | $27 | 5 | 0,00% | Aktien |
| Optiver Holding B.V. | $21 | 4 | 0,00% | Aktien |
Unternehmensinsider 15 Insider · 9 Führungskräfte · 7 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Krishna Vaddi | CEO | 15. Februar 2022 A | 1.053.519 | 0 | 0 | $0 |
| Laurent Chardonnet | Chief Financial Officer | 21. März 2022 A | 14.500 | 0 | 0 | $0 |
| Brian Piper | Chief Financial Officer | 25. August 2021 M | 0 | 0 | 0 | $0 |
| Jane Huang | President, CMO | 4. Juli 2023 M | 30.353 | 0 | 0 | $0 |
| Andrew Combs | EVP, Head of Chemistry | 1. April 2022 M | 304.442 | 0 | 0 | $0 |
| Peggy Scherle | Chief Scientific Officer | 15. Februar 2022 A | 172.920 | 0 | 0 | $0 |
| Deborah Morosini | EVP, Chief of Clinical Affairs | 15. Februar 2022 A | 444 | 0 | 0 | $0 |
| David J Mauro | Chief Medical Officer | 5. Oktober 2021 M | 0 | 0 | 0 | $0 |
| Christopher Pierce | EVP and Chief of Business Oper | 2. September 2021 M | 3.750 | 0 | 0 | $0 |
| Victor Sandor | Direktor | 9. Juni 2026 A | — | 0 | 0 | $0 |
| Katina Dorton | Direktor | 9. Juni 2026 A | — | 0 | 0 | $0 |
| David P Bonita | Direktor | 9. Juni 2026 A | — | 2 | 0 | $12.499.998 |
| Martin Babler | Direktor | 9. Juni 2026 A | — | 0 | 0 | $0 |
| Paul A Friedman, M.D. | Direktor | 9. Juni 2026 A | 500.098 | 0 | 0 | $0 |
| Mardi Dier | Direktor | 16. Juni 2023 A | 10.000 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP VI LLC, OrbiMed Genesis GP LLC, ORBIMED CAPITAL LLC ×4 Einreichungen | 23. April 2026 | 16,00% | Änderung | — | SEC |
| Baker Bros. Advisors LP, Baker Bros. Advisors (GP) LLC, Julian C. Baker, Felix J. Baker ×6 Einreichungen | 22. April 2026 | 15,50% | Änderung | Kapitalstruktur | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 13 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,03% | 19.657 SH | 8. August 2026 | Täglich |
| IWC · iShares Trust | 0,03% | 93.079 SH | 8. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 29.931 SH | 8. August 2026 | Täglich |
| IWO · iShares Trust | 0,01% | 254.408 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,00% | 644.659 SH | 8. August 2026 | Täglich |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 13.637 NS | 31. Mai 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 3.323 NS | 30. April 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 7.414 NS | 30. April 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 1.348 NS | 30. April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 458.355 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1.513.825 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 160.484 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.505 SH | 8. August 2026 | Täglich |